Author

Xiaoyong Zhi

Institution: Adimab (United States)

Observed institutions: Nanjing Agricultural University, Van Andel Institute, Adimab (United States), State Key Laboratory of Pharmaceutical Biotechnology, The University of Texas Southwestern Medical Center, Nanjing University

OpenAlex ID: A5037559706

Works count: 13

Citation count: 1,324

H-index: 11

I10-index: 11